Synthesis of two linear PADRE conjugates bearing a deca- or pentadecasaccharide B epitope as potential synthetic vaccines against Shigella flexneri serotype 2a infection.

No abstract is available for this paper.

• Publication year

  2005

• Venue

  Chemistry

• Publication date

  2005-02-18

• Fields of study

  Medicine, Chemistry

• Identifiers
  DOI 10.1002/CHEM.200400903PMID 15669066
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Simultaneous multiple synthesis and selective conjugation of cyclized peptides derived from a surface loop of a meningococcal class 1 outer membrane protein.

  2009cited by this paper
• Blockwise approach to fragments of the O-specific polysaccharide of Shigella flexneri serotype 2a: convergent Synthesis of a decasaccharide representative of a dimer of the branched repeating unit.

  2004cited by this paper
• Development of experimental carbohydrate-conjugate vaccines composed of Streptococcus pneumoniae capsular polysaccharides and the universal helper T-lymphocyte epitope (PADRE).

  2004cited by this paper
• Preparation of synthetic glycoconjugates as potential vaccines against Shigella flexneri serotype 2a disease.

  2004cited by this paper
• Short-chain oligosaccharide protein conjugates as experimental pneumococcal vaccines.

  2004cited by this paper
• A Synthetic Conjugate Polysaccharide Vaccine Against Haemophilus influenzae Type b

  2004cited by this paper
• Chemical synthesis of Haemophilus influenzae glycopeptide conjugates

  2004cited by this paper
• Chemoenzymatic synthesis of sulfated O-linked oligosaccharides: epitopes for MECA-79

  2002cited by this paper
• Errors in genomics and proteomics

  2002cited by this paper
• Immunogenicity in a Mouse Model of a Conjugate Vaccine Made with a Synthetic Single Repeating Unit of Type 14 Pneumococcal Polysaccharide Coupled to CRM197

  2002cited by this paper
• Synthesis of a spacer-armed disulfated tetrasaccharide of SB1a, a carbohydrate hapten associated with human hepatocellular carcinoma.

  2002cited by this paper
• Safety and Immunogenicity of ImprovedShigella O-Specific Polysaccharide-Protein Conjugate Vaccines in Adults in Israel

  2001cited by this paper
• Synthetic 6B Di-, Tri-, and Tetrasaccharide-Protein Conjugates Contain Pneumococcal Type 6A and 6B Common and 6B- Specific Epitopes That Elicit Protective Antibodies in Mice

  2001cited by this paper
• Revised interpretation of the immunological results obtained with pneumococcal polysaccharide 17F derived synthetic di-, tri- and tetrasaccharide conjugates in mice and rabbits.

  2001cited by this paper
• Rationally designed strings of promiscuous CD4+ T cell epitopes provide help to Haemophilus influenzae type b oligosaccharide: a model for new conjugate vaccines

  2001cited by this paper
• Safety and Immunogenicity of a Proteosome-Shigella flexneri 2a Lipopolysaccharide Vaccine Administered Intranasally to Healthy Adults

  2001cited by this paper
• Synthetic Polysaccharide Type 3-Related Di-, Tri-, and Tetrasaccharide–CRM197 Conjugates Induce Protection against Streptococcus pneumoniae Type 3 in Mice

  2001cited by this paper
• Synthesis of the Methyl Glycosides of a Di- and Two Trisaccharide Fragments Specific for the Shigella flexneri Serotype 2a O-Antigen

  2000cited by this paper
• Linear PADRE T Helper Epitope and Carbohydrate B Cell Epitope Conjugates Induce Specific High Titer IgG Antibody Responses1

  2000cited by this paper
• Global burden of Shigella infections: implications for vaccine development and implementation of control strategies.

  1999cited by this paper
• Protein conjugates of synthetic saccharides elicit higher levels of serum IgG lipopolysaccharide antibodies in mice than do those of the O-specific polysaccharide from Shigella dysenteriae type 1.

  1999cited by this paper
• Safety and immunogenicity of Shigella sonnei and Shigella flexneri 2a O-specific polysaccharide conjugates in children.

  1999cited by this paper
• Vaccination against Shigellosis with Attenuated Shigella flexneri 2a Strain SC602

  1999cited by this paper
• Double-blind vaccine-controlled randomised efficacy trial of an investigational Shigella sonnei conjugate vaccine in young adults.

  1997cited by this paper
• Epitope specificity of rabbit immunoglobulin G (IgG) elicited by pneumococcal type 23F synthetic oligosaccharide- and native polysaccharide-protein conjugate vaccines: comparison with human anti-polysaccharide 23F IgG

  1994cited by this paper
• Development of high potency universal DR-restricted helper epitopes by modification of high affinity DR-blocking peptides.

  1994cited by this paper
• Anomeric-oxygen activation for glycoside synthesis: the trichloroacetimidate method.

  1994cited by this paper
• Glycopeptides bind MHC molecules and elicit specific T cell responses.

  1993cited by this paper
• Protein-conjugated synthetic di- and trisaccharides of pneumococcal type 17F exhibit a different immunogenicity and antigenicity than tetrasaccharide.

  1993cited by this paper
• Synthesis, characterization, and clinical evaluation of conjugate vaccines composed of the O-specific polysaccharides of Shigella dysenteriae type 1, Shigella flexneri type 2a, and Shigella sonnei (Plesiomonas shigelloides) bound to bacterial toxoids

  1993cited by this paper
• Synthetic trimer and tetramer of 3-beta-D-ribose-(1-1)-D-ribitol-5-phosphate conjugated to protein induce antibody responses to Haemophilus influenzae type b capsular polysaccharide in mice and monkeys

  1992cited by this paper
• MHC interaction and T cell recognition of carbohydrates and glycopeptides.

  1992cited by this paper
• Use of human universally antigenic tetanus toxin T cell epitopes as carriers for human vaccination.

  1992cited by this paper
• The lipopolysaccharide of Shigella bacteria as a virulence factor.

  1991cited by this paper
• Prospective study of the association between serum antibodies to lipopolysaccharide O antigen and the attack rate of shigellosis

  1991cited by this paper
• Synthesis and 2D-n.m.r. analysis of a pentasaccharide glycoside of the biological repeating units of Shigella flexneri variant Y polysaccharide and the preparation of a synthetic antigen.

  1990cited by this paper
• Anomalous Zemplén deacylation reactions of 2-O-acyl-3-O-alkyl or -3-O-glycosyl derivatives of d-galactose and d-glucose: synthesis of O-α-d-mannopyranosyl-(1→4)-O-α-l-rhamnopyranosyl-(1→3)-d-galactose and an intermediate for the preparation of 2-O-glycosyl-3-O-(α-d-mannopyranosyl)-d-glucoses

  1990cited by this paper
• Anomalous Zemplén deacylation reactions of 2-O-acyl-3-O-alkyl or -3-O-glycosyl derivatives of D-galactose and D-glucose: synthesis of O-alpha-D-mannopyranosyl-(1----4)-O-alpha-L-rhamnopyranosyl-(1----3)-D- galactose and an intermediate for the preparation of 2-O-glycosyl-3-O-(alpha-D-mannopyranosyl)

  1990cited by this paper
• Comparison of four bifunctional reagents for coupling peptides to proteins and the effect of the three moieties on the immunogenicity of the conjugates.

  1989cited by this paper
• Oligosaccharides corresponding to biological repeating units of Shigella flexneri variant Y polysaccharide. 2. Synthesis and two-dimensional NMR analysis of a hexasaccharide hapten

  1989cited by this paper
• Serum antibodies to lipopolysaccharide and natural immunity to shigellosis in an Israeli military population.

  1988cited by this paper
• Glycosylated trehalose. Synthesis of the oligosaccharides of the glycolipid-type antigens from Mycobacterium smegmatis.

  1987cited by this paper
• Synthesis of the O-specific polysaccharide of

  1985cited by this paper
• Synthesis of 2-O-α-, 3-O-α-, 3-O-β-, and 4-O-α-l-rhamnopyranosyl-d-galactose

  1982cited by this paper
• USE OF CATIONIC IRIDIUM COMPLEX 1,5-CYCLOOCTADIENE-BIS-(METHYLDIPHENYLPHOSPHINE)-IRIDIUM HEXAFLUOROPHOSPHATE IN CARBOHYDRATE CHEMISTRY: SMOOTH ISOMERIZATION OF ALLYL ETHERS TO 1-PROPENYL ETHERS

  1981cited by this paper
• 1,2-Orthoacetate intermediates in silver trifluoromethanesulphonate promoted KoenigsKnorr synthesis of disaccharide glycosides'

  1979cited by this paper
• The allyl ether as a protecting group in carbohydrate chemistry.

  1974cited by this paper
• Immunochemistry of Shigella flexneri O-antigens: a study of structural and genetic aspects of the biosynthesis of cell-surface antigens.

  1971cited by this paper
• STUDIES ON ANTIBACTERIAL IMMUNITY INDUCED BY ARTIFICIAL ANTIGENS

  1939cited by this paper
• STUDIES ON ANTIBACTERIAL IMMUNITY INDUCED BY ARTIFICIAL ANTIGENS

  1939cited by this paper

• Characterization of Shigella virulence factor intracellular spread A (IcsA, or VirG) functional epitopes against S. flexneri 2a and S. sonnei invasion and adherence

  2025cites this paper
• Shigella Vaccines: The Continuing Unmet Challenge

  2024cites this paper
• Carriers and Antigens: New Developments in Glycoconjugate Vaccines

  2023cites this paper
• Advances in glycoside and oligosaccharide synthesis.

  2023cites this paper
• A Shigella flexneri 2a synthetic glycan-based vaccine induces a long-lasting immune response in adults

  2023cites this paper
• The First-in-Human Synthetic Glycan-Based Conjugate Vaccine Candidate against Shigella

  2022cites this paper
• Protecting group principles suited to late stage functionalization and global deprotection in oligosaccharide synthesis.

  2022cites this paper
• Synthetic Glycans to Improve Current Glycoconjugate Vaccines and Fight Antimicrobial Resistance

  2022cites this paper
• Toward a Multivalent Synthetic Oligosaccharide-Based Conjugate Vaccine against Shigella: State-of-the-Art for a Monovalent Prototype and Challenges

  2022cites this paper
• Multigram synthesis of an orthogonally protected pentasaccharide for use as glycan precursor in a Shigella flexneri 3a conjugate vaccine: application to a ready-for-conjugation decasaccharide

  2021cites this paper
• Conjugation Techniques and Linker Strategies for Carbohydrate-Based Vaccines

  2021cites this paper
• Oral Shigella Vaccines

  2020cites this paper
• Exploratory N‐Protecting Group Manipulation for the Total Synthesis of Zwitterionic Shigella sonnei Oligosaccharides

  2020cites this paper
• Safety and immunogenicity of a synthetic carbohydrate conjugate vaccine against Shigella flexneri 2a in healthy adult volunteers: a phase 1, dose-escalating, single-blind, randomised, placebo-controlled study.

  2020cites this paper
• A convergent chemoenzymatic strategy to deliver a diversity of Shigella flexneri serotype-specific O-antigen segments from a unique lightly protected tetrasaccharide core.

  2020cites this paper
• Classical and novel strategies to develop a Shigella glycoconjugate vaccine: from concept to efficacy in human

  2019cites this paper
• Recent Advances in the Synthesis of Glycoconjugates for Vaccine Development

  2018cites this paper
• Protein Carriers for Glycoconjugate Vaccines: History, Selection Criteria, Characterization and New Trends

  2018cites this paper
• Polysaccharides from Burkholderia species as targets for vaccine development, immunomodulation and chemical synthesis.

  2018cites this paper
• Bacteriophage Sf6 Tailspike Protein for Detection of Shigella flexneri Pathogens

  2018cites this paper
• Evaluation of a conjugate vaccine platform against enterotoxigenic Escherichia coli (ETEC), Campylobacter jejuni and Shigella.

  2018cites this paper
• Zwitterionic Polysaccharides of Shigella sonnei: Synthetic Study toward a Ready-for-Oligomerization Building Block Made of Two Rare Amino Sugars

  2018cites this paper
• Efficient Iterative Synthesis of O-Acetylated Tri- to Pentadecasaccharides Related to the Lipopolysaccharide of Shigella flexneri Type 3 a through Di- and Trisaccharide Glycosyl Donors.

  2017cites this paper
• Conditions of catalytic hydrogenolysis for the simultaneous reduction of azido group and debenzylation of chitooligosaccharides. Synthesis of biotinylated derivatives of chitooligosaccharides

  2016cites this paper
• A Synthetic Carbohydrate Conjugate Vaccine Candidate against Shigellosis: Improved Bioconjugation and Impact of Alum on Immunogenicity.

  2016cites this paper
• Detailed Investigation of the Immunodominant Role of O-Antigen Stoichiometric O-Acetylation as Revealed by Chemical Synthesis, Immunochemistry, Solution Conformation and STD-NMR Spectroscopy for Shigella flexneri 3a.

  2016cites this paper
• Status of vaccine research and development for Shigella.

  2016cites this paper
• Investigation on the Synthesis of Shigella flexneri Specific Oligosaccharides Using Disaccharides as Potential Transglucosylase Acceptor Substrates.

  2015cites this paper
• Programmed chemo-enzymatic synthesis of the oligosaccharide component of a carbohydrate-based antibacterial vaccine candidate.

  2015cites this paper
• Linear synthesis of the branched pentasaccharide repeats of O-antigens from Shigella flexneri 1a and 1b demonstrating the major steric hindrance associated with type-specific glucosylation.

  2014cites this paper
• Synthesis of the zwitterionic repeating unit of the O-antigen from Shigella sonnei and chain elongation at both ends.

  2014cites this paper
• Non-stoichiometric O-acetylation of Shigella flexneri 2a O-specific polysaccharide: synthesis and antigenicity.

  2014cites this paper
• CGTase‐Catalysed cis‐Glucosylation of L‐Rhamnosides for the Preparation of Shigella flexneri 2a and 3a Haptens

  2014cites this paper
• APC-Targeted (DNA) Vaccine Delivery Platforms: Nanoparticle Aided

  2014cites this paper
• A targeted and adjuvanted nanocarrier lowers the effective dose of liposomal amphotericin B and enhances adaptive immunity in murine cutaneous leishmaniasis.

  2013cites this paper
• Multidisciplinary Approaches to Study O-Antigen: Antibody Recognition in Support of the Development of Synthetic Carbohydrate-Based Enteric Vaccines

  2012cites this paper
• Stereoselective glycosylation of glucosamine: the role of the N-protecting group.

  2012cites this paper
• Glycodendrimers as functional antigens and antitumor vaccines

  2012cites this paper
• Applying pairwise combinations of amino acid mutations for sorting out highly efficient glucosylation tools for chemo-enzymatic synthesis of bacterial oligosaccharides.

  2012cites this paper
• Effects of backbone substitutions on the conformational behavior of Shigella flexneri O-antigens: implications for vaccine strategy.

  2011cites this paper
• Analysis of carbohydrates and glycoconjugates by matrix-assisted laser desorption/ionization mass spectrometry: an update for the period 2005-2006.

  2011cites this paper
• Carbohydrates and Immunology: Synthetic Oligosaccharide Antigens for Vaccine Formulation

  2011cites this paper
• Organic chemistry and immunochemical strategies in the design of potent carbohydrate-based vaccines.

  2011cites this paper
• Peptide-carbohydrate mimicry: synthesis and immunological evaluation of experimental bacterial vaccines

  2009cites this paper
• Stereocontrolled synthesis of mannans and rhamnans.

  2009cites this paper
• Rational design and immunogenicity of liposome-based diepitope constructs: application to synthetic oligosaccharides mimicking the Shigella flexneri 2a O-antigen.

  2009cites this paper
• Synthesis of L-Rhamnose and N -Acetyl-D-Glucosamine Derivatives Entering in the Composition of Bacterial Polysaccharides by Use of Glucansucrases

  2009cites this paper
• Structural mimicry of O-antigen by a peptide revealed in a complex with an antibody raised against Shigella flexneri serotype 2a.

  2009cites this paper
• Efficient synthesis of six tri- to hexasaccharide fragments of Shigella flexneri serotypes 3a and/or X O-antigen, including a study on acceptors containing N-trichloroacetylglucosamine versus N-acetylglucosamine.

  2009cites this paper
• A Synthetic Carbohydrate-Protein Conjugate Vaccine Candidate against Shigella flexneri 2a Infection1

  2009cites this paper
• Synthesis of Two Tetra- and Four Pentasaccharide Fragments of Shigella flexneri Serotypes 3a and X O-Antigens from a Common Tetrasaccharide Intermediate

  2008cites this paper
• Immunological Evidence for Functional Rather than Structural Mimicry by a Shigella flexneri Y Polysaccharide-Mimetic Peptide (cid:1)

  2008cites this paper
• Shigellose et infections à Escherichia coli entéro-invasifs

  2008cites this paper
• Glucane-saccharases optimisées pour la glucosylation de molécules intervenant dans la composition de vaccins

  2008cites this paper
• Efficient route to orthogonally protected precursors of 2-acylamino-2-deoxy-3-O -substituted-β-D -glucopyranose derivatives and use thereof

  2008cites this paper
• Biologically Relevant Glycopeptides: Synthesis and Applications

  2008cites this paper
• MIMICRY WITH A Shigella flexneri Y POLYSACCHARIDE-MIMETIC 2

  2008cites this paper
• Sucres et vaccins : du polysaccharide purifié au glycoconjugué semi-synthétique

  2008cites this paper
• Structures of synthetic O-antigen fragments from serotype 2a Shigella flexneri in complex with a protective monoclonal antibody

  2008cites this paper
• Vaccination against shigellosis: is it the path that is difficult or is it the difficult that is the path?

  2008cites this paper
• Immunological Evidence for Functional Rather than Structural Mimicry by a Shigella flexneri Y Polysaccharide-Mimetic Peptide

  2008cites this paper
• [Carbohydrates and vaccines: from purified polysaccharides to semi-synthetic glycoconjugate vaccines].

  2007cites this paper
• Toward a Better Understanding of the Basis of the Molecular Mimicry of Polysaccharide Antigens by Peptides

  2006cites this paper
• Characterization of Functional Oligosaccharide Mimics of the Shigella flexneri Serotype 2a O-Antigen: Implications for the Development of a Chemically Defined Glycoconjugate Vaccine1

  2006cites this paper
• Synthesis of Pentasaccharide Fragments Related to the O-Specific Polysaccharide of Shigella flexneri Serotype 1a†

  2006cites this paper
• Analysis of carbohydrates and glycoconjugates by matrix-assisted laser desorption/ionization mass spectrometry: an update covering the period 2001-2002.

  2006cites this paper